- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Major companies in pharmaceutical industry Japan 2018, by total assets
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Major companies in pharmaceutical industry Japan 2018, by total assets
Leading pharmaceutical companies in Japan as of March 2018, by total assets (in billion Japanese yen)
The statistic illustrates the leading pharmaceutical companies in Japan as of March 2018, ranked by total assets. In the period examined, Takeda Pharmaceutical Co., Ltd. topped the ranking with total assets worth approximately 4.1 trillion Japanese yen. Otsuka Holdings Co., Ltd. came in second with total assets of about 2.48 trillion yen.
Leading pharmaceutical companies in Japan as of March 2018, by total assets (in billion Japanese yen)
| Total assets in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Total assets in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Japan
- Survey time period
- March 2018
- Supplementary notes
-
*Total assets as of December 2017.
1 Japanese yen equals 0.00919 U.S. dollars or 0.00801 euros as of February 2019.
Figures have been rounded.
The source does not provide an exact publication date. Date given here is the day of the last update.
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Japan
- Survey time period
- March 2018
- Supplementary notes
-
*Total assets as of December 2017.
1 Japanese yen equals 0.00919 U.S. dollars or 0.00801 euros as of February 2019.
Figures have been rounded.
The source does not provide an exact publication date. Date given here is the day of the last update.
Other statistics on the topic
Pharmaceutical industry in Japan
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Global pharmaceutical market - revenue distribution 2010-2018, by region
+Pharmaceutical Products & Market
Takeda Pharmaceutical's revenue FY 2012-2018
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate solution including all features.
Prices do not include sales tax.
All Information
in one Presentation
- 64 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical industry in Japan " in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
- Global market and key figures
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Market size of the pharmaceutical industry in Japan from 2008 to 2015 (in trillion Japanese yen)Pharmaceutical market size Japan 2008-2015
- Production and trade
- Total value of medical drug production in Japan from 2007 to 2016 (in billion Japanese yen)Medical drug production value Japan 2007-2016
- Production value of prescription drugs in Japan from 2007 to 2016 (in trillion Japanese yen)Production value of prescription drugs Japan 2007-2016
- Distribution of the drug production value in Japan in 2016, by main therapeutic category of drugs*Breakdown of drug production value Japan 2016 by category
- Import value of medical and pharmaceutical products to Japan from 2010 to 2018 (in trillion Japanese yen)Import value of medical and pharmaceutical products to Japan 2010-2018
- Value of Japanese pharmaceutical drug exports from 2011 to 2016 (in billion Japanese yen)Value of exported pharmaceutical drugs from Japan 2011-2016
- Sales and expenses
- Sales share of the domestic drug market in Japan in 2017, by categoryJapan's drug market share 2017, by category
- Distribution of pharmaceutical sales in Japan from 2008 to 2017, by channelPharmaceutical sales share in Japan 2008-2017, by channel
- Distribution of ethical pharmaceuticals and over-the-counter (OTC) medication sales in Japan from 2008 to 2017Prescription and OTC drug sales share in Japan 2008-2017
- Revenue of pharmacy retail (SIC 47.73) in Japan from 2008 to 2018 (in million U.S. dollars)Forecast: pharmacy retail revenue Japan 2008-2018
- Revenue of pharmaceutical goods wholesale (SIC 46.46) in Japan from 2008 to 2018 (in million U.S. dollars)Forecast: pharmaceutical goods wholesale revenue Japan 2008-2018
- Research and development (R&D) expenditure as share of sales in the Japanese pharmaceutical industry from 2009 to 2015R&D spend in relation to pharma sales Japan 2009-2015
- Advertising expenses of the pharmaceutical and medical industry through traditional media in Japan from 2008 to 2017 (in billion Japanese yen)*Japanese ad spend pharmaceuticals industry 2008-2017
- Companies
- Leading pharmaceutical companies in Japan as of March 2018, by total assets (in billion Japanese yen)Major companies in pharmaceutical industry Japan 2018, by total assets
- Revenue of Takeda Pharmaceutical Co., Ltd. from fiscal year 2012 to 2018 (in trillion Japanese yen)Takeda Pharmaceutical's revenue FY 2012-2018
- Net sales of Otsuka Pharmaceutical Co., Ltd. in fiscal years 2008 to 2017 (in trillion Japanese yen)Otsuka Pharmaceutical's net sales 2008-2017
- Annual revenue of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in billion Japanese yen)Daiichi Sankyo's net sales FY 2012-2017
- Number of medical drug manufacturing plants in Japan in 2016, by employee size*Number of medical drug manufacturing plants Japan 2016, by employee size
- Leading generics manufacturers in Japan as of March 2018, by net sales (in billion Japanese yen)Leading generics makers Japan 2018, by net sales
- Outlook and future trends
- Forecast of the total population in Japan from 2018 to 2110, by age group (in millions)Projection of the population Japan 2018-2110 by age group
- Number of pharmaceutical products approved by the Pharmaceuticals and Medical Devices Agency in Japan in fiscal year 2017, by typeApproval number pharmaceutical products Japan FY 2017, by type
- Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen)Biopharmaceutical market size forecast Japan 2011-2020
- Volume share of generics in the Japanese pharmaceutical market from 2005 to 2017Volume share of generics in pharmaceutical market Japan 2017
- Projected market size of the biosimilars industry in Japan from 2011 to 2020 (in billion Japanese yen)Biosimilar market size forecast Japan 2011-2020
- Ono Pharmaceutical's total assets FY 2012-2017
- Astellas Pharma's total assets FY 2008-2017
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Towa Pharmaceutical's profit FY 2012-2017
- Towa Pharmaceutical's sales revenue FY 2012-2017
- Fuji Pharma's net sales composition FY 2018, by therapeutic category
- Fuji Pharma's sales composition FY 2018, by therapeutic category
- Towa Pharmaceutical's R&D expenses FY 2012-2017
- Takeda Pharmaceutical's total assets FY 2012-2018
- Fuji Pharma's R&D costs FY 2013-2018
- Towa Pharmaceutical's total assets FY 2012-2017
- Fuji Pharma's net sales FY 2013-2018
- Fuji Pharma's total assets FY 2013-2018
- Towa Pharmaceutical's sales share FY 2016, by channel
- Fuji Pharma's operating profit FY 2013-2018
- Personnel costs of the manufacture of pharmaceutical products in Germany 2008-2016
- Toei's assets FY 2013-2017
- Value of imports of pharmaceutical products from Finland to Spain 2012-2016
- U.S. branded and generic pharmaceutical revenue and profit 2012
- Ono Pharmaceutical's profit FY 2012-2017
- Pharmaceutical industry in Scandinavia
- Pharmaceutical industry in India
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical industry in the Netherlands
- Pharmaceutical trends in Europe
- Vaccine industry in China
- 2019 PhRMA Annual Membership Survey
- Indicatori Farmaceutici
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Generic Pharmaceutical Industry Yearbook 2016
- LEO Pharma A/S Annual Report 2017
- Dechra Pharmaceuticals PLC Annual Report 2018
- 2018 PhRMA Annual Membership Survey
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.